Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Androgen receptor signaling in prostate cancer and therapeutic strategies
Aasems Jacob
, Rishi Raj
,
Derek B. Allison
,
Zin W. Myint
Pathology and Lab Medicine
Markey Cancer Center / Cancer Research Priority Initiative
Urology
Translational Oncology Research Program
Internal Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
123
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Androgen receptor signaling in prostate cancer and therapeutic strategies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Prostate Cancer
100%
Androgen Receptor
100%
Cell Signaling Pathway
18%
Androgen
18%
Clinical Trial
9%
DNA Repair
9%
Androgen Synthesis
9%
Abiraterone
9%
Androgen Receptor Antagonist
9%
MAPK Signaling
9%
Darolutamide
9%
Apalutamide
9%
PI3K/AKT/mTOR Pathway
9%
Drug Resistance
9%
Wnt Signaling
9%
Enzalutamide
9%
Glucocorticoid Receptor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen Receptor
100%
Androgen
27%
Clinical Trial
9%
Enzalutamide
9%
Abiraterone
9%
Androgen Receptor Antagonist
9%
Darolutamide
9%
Apalutamide
9%
Glucocorticoid Receptor
9%
Drug Resistance
9%
Protein Kinase B
9%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Clinical Trial
8%
Wnt Signaling Pathway
8%
PI3K/AKT/mTOR Pathway
8%
DNA Repair
8%
Receptor Antagonist
8%
MAPK Signaling
8%
Androgen Synthesis
8%
Drug Resistance
8%
Glucocorticoid Receptor
8%
Enzalutamide
8%